The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Cassava Sciences's Revenue for the
three
months ended in Dec. 2023 was $0.00 Mil. Cassava Sciences's average Accounts Receivable for the
three
months ended in Dec. 2023 was $0.00 Mil.
Cassava Sciences Receivables Turnover Historical Data
The historical data trend for Cassava Sciences's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cassava Sciences's Receivables Turnover
For the Biotechnology subindustry, Cassava Sciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cassava Sciences's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cassava Sciences's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Cassava Sciences's Receivables Turnover falls into.
Cassava Sciences Receivables Turnover Calculation
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
Cassava Sciences's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Cassava Sciences Receivables Turnover Related Terms
Thank you for viewing the detailed overview of Cassava Sciences's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Cassava Sciences (Cassava Sciences) Business Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SAVA has been successfully added to your 